TECHNICAL FIELD

Embodiments of the present disclosure generally relate to compositions and methods for inhibiting corrosion and, more specifically, to corrosion inhibitor formulations based on compounds with both pyridinium and hydroxy substituents and their use for mitigating corrosion of a metallic surface.

BACKGROUND

Corrosion is the irreversible interfacial reaction of a material with its environment, which results in the consumption of the material. According to a recent report by the National Association of Corrosion Engineers (NACE), the annual worldwide cost of corrosion is over 2.5 trillion U.S. dollars. In the oil and gas industry, corrosion can inflict severe damage on the internal walls of production and transportation pipelines, which are mostly steel based materials. Specifically, corrosion can lead to pipeline leakages and, in some cases, bursting. Such damage can result in high maintenance costs, discontinuity of operations, and low capacity production.

Sources of corrosion of metal surfaces include dissolved gasses, such as carbon dioxide (CO₂), which causes “sweet corrosion,” and hydrogen sulfide (H₂S), which causes “sour corrosion.” Once dissolved in water, both CO₂and H₂S behave like weak acids and can provide oxidizing power, which promotes steel corrosion. The more dominant of either sweet or sour corrosion in oilfield pipelines depends on the relative abundance of each gas in the environment. To mitigate sweet and sour corrosion during oil and gas production, transportation, and processing, corrosion inhibitors are commonly injected into pipeline fluids.

Mitigating pipeline corrosion in wet sour environments is a particular challenge for the oil and gas industry. Some of the most common corrosion inhibitor formulations are film formers based on nitrogen-containing compounds. They retard metallic corrosion by adsorbing onto the metal surface to create inhibitor barriers between the metal surface and the corrosive environment. Notable classes of corrosion inhibitor formulations include nitrogen-based compounds such as imidazolines, amines, and quaternary ammonium salts. Commonly used corrosion inhibitor formulations to mitigate corrosion in a wet sour environment include alkyl pyridinium benzyl quaternary ammnonium salts (APBQA). APBQAs form a relatively weak film barrier between the fluid phase and the metal surface. Thus, a high dosage of APBQA based corrosion inhibitor formulations is needed to significantly mitigate corrosion in a wet sour environment.

There is a need for corrosion inhibitor formulations that form a strong film barrier between the fluid phase and the metal surface of pipelines at lower dosages.

SUMMARY

Embodiments of the corrosion inhibitor formulations described herein meet this need through the inclusion of compounds comprising both pyridinium and hydroxy substituents. Such formulations exhibit superior corrosion inhibition efficiency relative to conventional corrosion inhibitor formulations in a wet sour environment even when applied at lower dosages.

In one or more embodiments, a compound for inhibiting corrosion is provided. The compound comprises Formula (I):

[Image Omitted]

or a salt thereof. R¹, R², R³, R⁴, and R⁵are independently hydrogen, substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide. R⁶is a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide.

In some embodiments, a method of making the compound is provided. The method includes reacting a pyridine comprising Formula (II):

[Image Omitted]

or a salt thereof, with an epoxide comprising Formula (III):

[Image Omitted]

in the presence of an acid to produce the compound. R¹, R², R³, R⁴, and R⁵are independently hydrogen, substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide. R⁶is a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide.

In one or more embodiments, a sour well fluid including the compound at a concentration by weight of 0.1 parts per million to 100 parts per million of the well fluid is provided.

In some embodiments, a formulation for inhibiting corrosion is provided. The formulation includes the compound and water.

In one or more embodiments, a process for inhibiting corrosion is provided. The process includes contacting a metallic surface with the formulation.

In some embodiments, a process for inhibiting corrosion includes adding the formulation to a well fluid to effect a concentration by weight of the formulation in the well fluid of from 0.5 parts per million to 500 parts per million.

Additional features and advantages of the described embodiments will be set forth in the detailed description which follows, and in part will be readily apparent to those skilled in the art from that description or recognized by practicing the described embodiments, including the detailed description which follows, the claims, as well as the appended drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

The following detailed description of specific embodiments of the present disclosure can be best understood when read in conjunction with the following drawings, where like structure is indicated with like reference numerals and in which:

FIG. 1A is a ¹H nuclear magnetic resonance (NMR) spectrum of an embodiment of an active component according to embodiments described herein;

FIG. 1B is a ¹³C NMR spectrum of an embodiment of an active component according to embodiments described herein;

Reference will now be made in greater detail to various embodiments, some embodiments of which are illustrated in the accompanying drawings.

DETAILED DESCRIPTION

As used herein, the term “active component” is defined as a component in a corrosion inhibitor formulation that acts to mitigate corrosion of a material. Active components are distinguished from inactive components, which mainly serve as a vehicle to convey an active component. Corrosion inhibitor formulations according to embodiments described herein may include one or more active components.

As used herein, “the active component” refers to the component in a corrosion inhibitor formulation that acts to mitigate corrosion of a material to a greater extent than any other individual component in the corrosion inhibitor formulation.

It was discovered that embodiments of compounds described herein that include both a hydroxy substituent and a pyridinium substituent exhibit superior corrosion inhibiting efficiency compared with conventional corrosion inhibitors. Without being bound by theory, it is believed that compounds including both a pyridinium substituent and a hydroxy substituent are capable of forming a stronger film barrier between a fluid phase and a metal surface than conventional corrosion inhibitors. Specifically, it is believed that compounds according to embodiments described herein may form a particularly strong bond with a metal surface because the hydroxy substituent chemically adsorbs onto the metal and the pyridinium substituent adsorbs onto the metal through both chemical and physical interactions owing to its positive charge and sp²hybridization. Thus, it is believed that conventional corrosion inhibitors that do not include both a pyridinium substituent and a hydroxy substituent form a weaker bond with a metal surface than compounds according to embodiments described herein. As such, conventional corrosion inhibitors may be less effective at mitigating corrosion of metal surfaces than compounds according to embodiments described herein.

According to embodiments, a compound for inhibiting corrosion includes Formula (I):

[Image Omitted]

or a salt thereof. In some embodiments, R¹, R², R³, R⁴, and R⁵in Formula I are independently hydrogen, substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide. According to embodiments, R¹, R², R³, R⁴, and R⁵in Formula I are independently hydrogen, a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, or a substituted or unsubstituted alkynyl. In some embodiments, R¹, R², R³, R⁴, and R⁵in Formula I are independently hydrogen.

According to one or more embodiments, R⁶in Formula I is a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide. In some embodiments, R⁶in Formula I is a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, or a substituted or unsubstituted alkynyl. According to embodiments, R⁶in Formula I is a substituted or unsubstituted C₁to C₂₄alkyl. In some embodiments, R⁶in Formula I is a substituted or unsubstituted C₅to C₁₅alkyl. Without being bound by theory, it is believed that the presence of a long alkyl chain may facilitate bonding with a metal surface. Further, it is believed that the presence of a long alkyl chain may provide superior protection against corrosion.

In some embodiments, a method of making the compound comprises reacting a pyridine comprising Formula (II):

[Image Omitted]

or a salt thereof, with an epoxide comprising Formula (III):

[Image Omitted]

in the presence of an acid to produce the compound. In some embodiments, R¹, R², R³, R⁴, and R⁵in Formula II are independently hydrogen, substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide. According to embodiments, R¹, R², R³, R⁴, and R⁵in Formula II are independently hydrogen, a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, or a substituted or unsubstituted alkynyl. In some embodiments, R¹, R², R³, R⁴, and R⁵in Formula II are independently hydrogen.

According to one or more embodiments, R⁶in Formula II is a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide. In some embodiments, R⁶in Formula II is a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, or a substituted or unsubstituted alkynyl. According to embodiments, R⁶in Formula II is a substituted or unsubstituted C₁to C₂₄alkyl. In some embodiments, R⁶in Formula II is a substituted or unsubstituted C₅to C₁₅alkyl.

In some embodiments, the acid comprises hydrochloric acid, sulfuric acid, phosphoric acid, hydrobromic acid, acetic acid, nitric acid, or a combination thereof. In embodiments, the acid comprises hydrochloric acid, phosphoric acid, sulfuric acid, or a combination thereof. According to one or more embodiments, the acid comprises hydrochloric acid.

In embodiments, the compound may be used to mitigate corrosion of a material. In some embodiments, the compounds may be used to mitigate corrosion of a metallic surface, such as a metallic surface in a wet sour environment. According to one or more embodiments, the compounds may be included in a sour well fluid to mitigate the corrosion of surfaces exposed to the sour well fluid. Thus, a sour well fluid may include the compound at a concentration by weight of 0.1 parts per million to 100 parts per million, 0.2 parts per million to 50 parts per million, 0.2 parts per million to 40 parts per million, 0.2 parts per million to 30 parts per million, 0.2 parts per million to 20 parts per million, 0.2 parts per million to 10 parts per million, 0.3 parts per million to 8 parts per million, 0.4 parts per million to 6 parts per million, 0.5 parts per million to 5 parts per million, 0.5 parts per million to 2 parts per million, or 1 part per million to 2 parts per million of the well fluid. In embodiments, the sour well fluid may further comprise petroleum hydrocarbons.

In embodiments, a process for mitigating corrosion of a metallic surface may include contacting the metallic surface with a solution comprising the compound at a concentration by weight of 0.1 parts per million to 100 parts per million, 0.2 parts per million to 50 parts per million, 0.2 parts per million to 40 parts per million, 0.2 parts per million to 30 parts per million, 0.2 parts per million to 20 parts per million, 0.2 parts per million to 10 parts per million, 0.3 parts per million to 8 parts per million, 0.4 parts per million to 6 parts per million, 0.5 parts per million to 5 parts per million, 0.5 parts per million to 2 parts per million, or 1 part per million to 2 parts per million of the well fluid. According to embodiments, the metallic surface comprises steel. In some embodiments, the metallic surface comprises carbon steel. In embodiments, the metallic surface may be contacted with the corrosion inhibitor at least one time, at least two times, at least three times, at least four times, or even at least five times. It should be understood that when the metallic surface is contacted with the corrosion inhibitor multiple times, each contacting may be accomplished using the same or different concentrations of the compound described herein.

In some embodiments, the compound described herein may be used as an active component in a formulation for inhibiting corrosion. According to one or more embodiments, a corrosion inhibitor formulation comprises the compound and water. In some embodiments, the corrosion inhibitor formulation further comprises a synergist, a surfactant, a supporting component, a secondary solvent, a coupling agent, an ethoxylated amine, or a combination thereof.

According to one or more embodiments, the compound is present in the corrosion inhibitor formulation at a concentration of from 0.1 to 50 weight percent, 0.2 to 40 weight percent, 0.3 to 40 weight percent, 0.5 to 40 weight percent, 1 to 40 weight percent, 2 to 40 weight percent, 3 to 40 weight percent, 4 to 40 weight percent, 5 to 40 weight percent, 5 to 35 weight percent, 5 to 30 weight percent, 5 to 25 weight percent, 5 to 20 weight percent, or 10 to 20 weight percent. In embodiments, water is present in the corrosion inhibitor formulation at a concentration of from 20 to 99.9 weight percent, 20 to 99 weight percent, 20 to 95 weight percent, 20 to 90 weight percent, 30 to 90 weight percent, 40 to 90 weight percent, 50 to 90 weight percent, 50 to 80 weight percent, 60 to 80 weight percent, or 65 to 75 weight percent.

In some embodiments, the corrosion inhibitor formulation includes a synergist. The synergist may act to facilitate the adsorption of an active component comprising a quaternary ammonium or pyridinium substituent onto the surface of a metal. Without being bound by theory, it is believed that the synergist adsorbs onto a metal surface while also attracting an active component comprising a quaternary ammonium or pyridinium substituent. In some embodiments, the synergist comprises a thiol substituent. In other embodiments, the synergist is an alkyl iodide. According to one or more embodiments, the synergist is thioglycolic acid, 2-mercaptoethanol, or a combination thereof. In embodiments, the synergist is present in the corrosion inhibitor formulation at a concentration of from 0.1 to 20 weight percent, 0.2 to 20 weight percent, 0.3 to 20 weight percent, 0.5 to 20 weight percent, 1 to 20 weight percent, 1 to 15 weight percent, 1 to 10 weight percent, 2 to 10 weight percent, 2 to 8 weight percent, or 2 to 6 weight percent.

In embodiments, the corrosion inhibitor formulation includes a secondary solvent. The secondary solvent may act to clean the metal for adsorption of an active component. In embodiments, the secondary solvent comprises ethylene glycol, ethylene diamine, or combinations thereof. According to one or more embodiments, the secondary solvent is present in the corrosion inhibitor formulation at a concentration of from 0.1 to 20 weight percent, 0.2 to 20 weight percent, 0.3 to 20 weight percent, 0.5 to 20 weight percent, 1 to 20 weight percent, 1 to 15 weight percent, 1 to 10 weight percent, 1 to 8 weight percent, 1 to 6 weight percent, or 2 to 5 weight percent.

According to one or more embodiments, the corrosion inhibitor formulation includes a surfactant. In embodiments, the surfactant comprises an ethoxylated alcohol. According to one or more embodiments, the ethoxylated alcohol comprises a carbon chain length of C₅to C₂₀, C₈to C₁₈, C₁₀to C₁₅, or C₁₂to C₁₄. According to one or more embodiments, the surfactant is present in the corrosion inhibitor formulation at a concentration of from 0.1 to 10 weight percent, 0.1 to 5 weight percent, 0.1 to 2 weight percent, 0.2 to 2 weight percent, 0.2 to 1.5 weight percent, 0.2 to 1 weight percent, 0.2 to 0.8 weight percent, 0.2 to 0.6 weight percent, 0.3 to 0.6 weight percent, or 0.4 to 0.6 weight percent.

In embodiments, the corrosion inhibitor formulation includes a coupling agent. The coupling agent may act to mitigate phase separation of components in the corrosion inhibitor formulation. The risk of phase separation may be especially acute in environments with a large temperature range. According to one or more embodiments, the coupling agent is an alkyl imino dipropionic acid sodium salt. In embodiments, the coupling agent is present in the corrosion inhibitor formulation at a concentration of from 0.1 to 10 weight percent, 0.1 to 5 weight percent, 0.2 to 5 weight percent, 0.3 to 5 weight percent, 0.3 to 3 weight percent, 0.3 to 2 weight percent, 0.5 to 2 weight percent, 0.5 to 1.5 weight percent, 0.7 to 1.5 weight percent, or 0.8 to 1.2 weight percent.

In some embodiments, the corrosion inhibitor formulation includes an ethoxylated amine. The ethoxylated amine may facilitate film formation and neutralize acids present in the environment. In embodiments, the ethoxylated amine is present in the corrosion inhibitor formulation at a concentration of from 0.1 to 10 weight percent, 0.1 to 5 weight percent, 0.2 to 5 weight percent, 0.3 to 5 weight percent, 0.3 to 3 weight percent, 0.3 to 2 weight percent, 0.5 to 2 weight percent, 0.5 to 1.5 weight percent, 0.7 to 1.5 weight percent, or 0.8 to 1.2 weight percent.

According to one or more embodiments, the corrosion inhibitor formulation includes a supporting component. The supporting component may act cooperatively, along with the active component, to mitigate corrosion. In some embodiments, the supporting component mitigates sweet corrosion in wet environments containing both CO₂and H₂S. According to one or more embodiments, the supporting component comprises imidazoline. In embodiments, imidazoline is present in the corrosion inhibitor formulation at a concentration of from 0.1 to 20 weight percent, 0.2 to 20 weight percent, 0.3 to 20 weight percent, 0.5 to 20 weight percent, 1 to 20 weight percent, 1 to 15 weight percent, 1 to 10 weight percent, 2 to 10 weight percent, 2 to 8 weight percent, or 2 to 6 weight percent.

In embodiments, a process for inhibiting corrosion includes contacting a metallic surface with a corrosion inhibitor formulation according to embodiments described herein. According to embodiments, the metallic surface comprises steel. In some embodiments, the metallic surface comprises carbon steel. In embodiments, the metallic surface may be contacted with a solution containing the corrosion inhibitor formulation at a concentration by weight of 0.5 parts per million to 500 parts per million, 0.5 parts per million to 200 parts per million, 0.5 parts per million to 100 parts per million, 0.5 parts per million to 50 parts per million, 1 part per million to 50 parts per million, 1 part per million to 40 parts per million, 2 part per million to 40 parts per million, 2 part per million to 30 parts per million, 3 part per million to 30 parts per million, 3 part per million to 20 parts per million, 5 part per million to 20 parts per million, or 5 part per million to 15 parts per million. In embodiments, the metallic surface may be contacted with the corrosion inhibitor formulation at least one time, at least two times, at least three times, at least four times, or even at least five times. It should be understood that when the metallic surface is contacted with the corrosion inhibitor formulation multiple times, each contacting may be accomplished using the same or different concentrations of the compound described herein.

Many oil and gas processing facilities such as gas oil separation plants and pipelines include metallic surfaces exposed to sour well fluids. Thus, adding the corrosion inhibitor formulation described herein to the sour well fluids may mitigate corrosion of the metallic surfaces. Thus, according to one or more embodiments, a process for inhibiting corrosion includes adding the corrosion inhibitor formulation described herein to a well fluid to effect a concentration by weight of the formulation in the well fluid of from 0.5 parts per million to 500 parts per million, 0.5 parts per million to 200 parts per million, 0.5 parts per million to 100 parts per million, 0.5 parts per million to 50 parts per million, 1 part per million to 50 parts per million, 1 part per million to 40 parts per million, 2 part per million to 40 parts per million, 2 part per million to 30 parts per million, 3 part per million to 30 parts per million, 3 part per million to 20 parts per million, 5 part per million to 20 parts per million, or 5 part per million to 15 parts per million.

Corrosion inhibitor formulations described herein may exhibit a higher corrosion inhibition efficiency than conventional corrosion inhibitor formulations. In embodiments, corrosion inhibitor formulations described herein may exhibit a corrosion inhibition efficiency that is at least 5%, at least 10%, at least 15%, at least 20%, at least 25%, or at least 30% greater than conventional corrosion inhibitor formulations. Because embodiments of the corrosion inhibitor formulations described herein exhibit a greater corrosion inhibition efficiency than conventional corrosion inhibitor formulations, a lower dosage of the corrosion inhibitor formulations described herein may provide a metallic surface with the same or even greater protection from corrosion than a higher dosage of a conventional corrosion inhibitor formulation. As such, corrosion inhibitor formulations described herein may be more efficient and cost-effective than conventional corrosion inhibitor formulations.

According to an aspect, either alone or in combination with any other aspect, a compound for inhibiting corrosion includes Formula (I):

[Image Omitted]

or a salt thereof. R¹, R², R³, R⁴, and R⁵are independently hydrogen, substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide. R⁶is a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide.

According to a second aspect, either alone or in combination with any other aspect, the compound includes Formula (I) where R⁶is a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, or a substituted or unsubstituted alkynyl.

According to a third aspect, either alone or in combination with any other aspect, the compound includes Formula (I) where R⁶is a substituted or unsubstituted C₁to C₂₄alkyl.

According to a fourth aspect, either alone or in combination with any other aspect, the compound includes Formula (I) where R⁶is a substituted or unsubstituted C₅to C₁₅alkyl.

According to a fifth aspect, either alone or in combination with any other aspect, the compound includes Formula (I) where: R¹, R², R³, R⁴, and R⁵are independently hydrogen; and R⁶is an unsubstituted C₅to C₁₅alkyl.

According to a sixth aspect, either alone or in combination with any other aspect, a method of making the compound includes reacting a pyridine comprising Formula (II):

[Image Omitted]

or a salt thereof, with an epoxide comprising Formula (III):

[Image Omitted]

in the presence of an acid to produce the compound. R¹, R², R³, R⁴, and R⁵are independently hydrogen, substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide. R⁶is a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, sulfonate, aryl sulfonate, C₁to C₂₄alkyl sulfonate, taurine, carboxylate, amine, alkylamine, arylamine, alkylammonium, arylammonium, sulfonamide, halogen, hydroxy, amide, nitro, cyano, azide, O-alkyl, S-alkyl, silyl, trialkylsilyl, O-silyl, haloalkyl, alkylsulfhydryl, trifluoromethyl, hydrazide, substituted or unsubstituted aryl, heteroaryl, or heterocyclic alkynyl, carboxyalkyl, aminoalkyl, haloalkyl, azidoalkyl, amide, amino acid, or peptide.

According to a seventh aspect, either alone or in combination with any other aspect, the method includes Formula (III) where R⁶is a substituted or unsubstituted C₁to C₂₄alkyl, substituted or unsubstituted alkylaryl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, substituted or unsubstituted alkenyl, or a substituted or unsubstituted alkynyl.

According to an eighth aspect, either alone or in combination with any other aspect, the method includes Formula (III) where R⁶is a substituted or unsubstituted C₁to C₂₄alkyl.

According to a ninth aspect, either alone or in combination with any other aspect, the method includes Formula (III) where R⁶is a substituted or unsubstituted C₅to C₁₅alkyl.

According to a tenth aspect, either alone or in combination with any other aspect, the method includes Formula (II) where R¹, R², R³, R⁴, and R⁵are independently hydrogen; and Formula (III) where R⁶is an unsubstituted C₅to C₁₅alkyl.

According to an eleventh aspect, either alone or in combination with any other aspect, a sour well fluid includes the compound at a concentration by weight of 0.1 parts per million to 100 parts per million of the well fluid.

According to a twelfth aspect, either alone or in combination with the eleventh aspect, the sour well fluid includes the compound at a concentration by weight of 0.2 parts per million to 20 parts per million.

According to a thirteenth aspect, either alone or in combination with any other aspect, the sour well fluid includes petroleum hydrocarbons.

According to a fourteenth aspect, either alone or in combination with any other aspect, a formulation for inhibiting corrosion includes the compound and water.

According to a fifteenth aspect, either alone or in combination any other aspect, the formulation includes a synergist.

According to a sixteenth aspect, either alone or in combination with any other aspect, the formulation includes a nonionic surfactant, imidazoline, a secondary solvent, a coupling agent, and an ethoxylated amine.

According to a seventeenth aspect, either alone or in combination with any other aspect, the formulation includes the compound at a concentration of from 5 to 25 weight percent; water at a concentration of from 40 to 90 weight percent; imidazoline at a concentration of from 1 to 10 weight percent; and the synergist includes thioglycollic acid, 2-mercaptoethanol, or a mixture thereof.

According to an eighteenth aspect, either alone or in combination with any other aspect, a process for inhibiting corrosion includes contacting a metallic surface with the formulation.

According to a nineteenth aspect, either alone or in combination with the eighteenth aspect, the metallic surface includes steel.

According to a twentieth aspect, either alone or in combination with any other aspect, a process for inhibiting corrosion includes adding the formulation to a well fluid to effect a concentration by weight of the formulation in the well fluid of from 0.5 parts per million to 500 parts per million.

EXAMPLES

Using embodiments described above, an exemplary corrosion inhibitor was prepared and used according to the following examples. The examples are illustrative in nature, and should not be understood to limit the subject matter of the present disclosure.

Example 1: Preparation of Active Component 1

Preparation of Active Component 1 is achieved substantially as depicted in Scheme I:

[Image Omitted]

Briefly, pyridine (1.5 moles, Aldrich) and hydrochloric acid (1 mole, 37% solution in water, Aldrich) were added to a round bottom flask. The resulting mixture was purged with nitrogen and stirred at room temperature for 10 minutes. 1,2-epoxydodecane (1 mole, Aldrich) was added and the resulting mixture was stirred for 30 minutes at room temperature. The reaction mixture was then stirred at 110° C. for 6 hours before being cooled to room temperature. Excess pyridine was removed by rotary evaporation. Active Component 1 was then precipitated by addition of diethyl ether (Aldrich).

The structure of Active Component 1 was confirmed by nuclear magnetic resonance (NMR) spectroscopy. Specifically, a sample of Active Component 1 was dissolved in deuterated water (D₂O) and its ¹H NMR and ¹³C NMR spectra were obtained using a 500 MHz NMR spectrometer with appropriate acquisition parameters. Chemical shifts were set to those of deuterated trimethylsilylpropanoic acid (0 ppm). The ¹H NMR and ¹³C NMR spectra are shown in FIG. 1A and FIG. 1B respectively.

Referring to FIG. 1A, the ¹H NMR spectrum of Active Component 1 shows the pyridinium protons having a chemical shift of 9.01 ppm, 8.78 ppm, and 8.27 ppm. The protons on the carbon alpha to the pyridinium have a chemical shift of 5.00 ppm and 4.63 ppm. The proton on the carbon beta to the pyridinium and alpha to the hydroxy group has a chemical shift of 4.25 ppm. The protons on the carbon gamma to the pyridinium and beta to the hydroxy group have a chemical shift of 1.72 ppm. The remainder of the CH₂protons are at 1.48 ppm while the CH₃protons are present at 1.06 ppm.

Referring to FIG. 1B, the ¹³C NMR spectrum of Active Component 1 shows the pyridinium carbons having a chemical shift of 146.3 ppm, 145.0 ppm, and 128.3 ppm. The carbon alpha to the pyridinium has a chemical shift of 66.9 ppm. The carbon beta to the pyridinium and alpha to the hydroxy group has a chemical shift of 70.5 ppm. The remainder of the carbons have chemical shifts between 10.0 ppm and 35.0 ppm.

Example 2: Preparation of Corrosion Inhibitors

Corrosion Inhibitor Formulation 1 (CIF-1), Comparative Corrosion Inhibitor Formulation 1 (CCIF-1), and Comparative Corrosion Inhibitor Formulation 2 (CCIF-2) were prepared according to the general formula shown in Table 1. The identity of the Active Compound in each corrosion inhibitor formulation is shown in Table 2.

TABLE 1

General Formula of Corrosion Inhibitor Formulations

Component
Weight (%)

Water
70.4

Thioglycollic Acid
2.8

2-Merceptoethanol
1.5

Ethylene Glycol
1.5

Ethylene Diamine
1.5

Long Chain Ethoxylated Alcohol
0.5

Ethoxylated Amine
0.9

Alkyl Imino Dipropionic Acid Sodium Salt
0.9

Imidazoline
5.0

Active Component
15.0

TABLE 2

Identity of the Active Component in

Each Corrosion Inhibitor Formulation

Corrosion Inhibitor
Active Component

CIF-1
Active Component 1

CCIF-1
Dodecyl pyridinium

CCIF-2
Imidazoline

Example 3: Performance of Corrosion Inhibitors

The corrosion inhibition efficiency of CIF-1, CCIF-1, CCIF-2, and a conventional corrosion inhibitor formulation (CCIF-3) were evaluated in four experiments. In CCIF-3, the active component was an alkyl pyridinium benzyl chloride, and the inactive components included an alkoxylated fatty amine, nonylphenol, and an alcohol. Experiments were performed using a four-liter high temperature and high pressure (HTHP) autoclave rotating cage made from C-276 alloy, which withstands harsh corrosive environments. Briefly, carbon steel C-1018 coupons were cleaned and degreased following ASTM G1. The coupons were positioned in a fixed cage made from polyether ether ketone (PEEK), which was then mounted in the autoclave. To simulate field conditions, a 1:1 mixture of kerosene and water comprising the corrosion inhibitor formulation was mixed at room temperature. The water used had a pH of 6.6. The geochemical analysis of the water is shown in Table 3. The concentration of the corrosion inhibitor formulation in the mixture for each respective test is shown in Table 4. After 2 hours, the kerosene was removed and the remaining water was used in the autoclave for the test. The autoclave was pressurized to 250 psi with a gas comprising 7 mole % CO₂, 3 mole % H₂S, and 90 mole % N₂and heated to a temperature of 182° F. The cage was rotated at 400 RPM for 24 hours.

TABLE 3

Water Geochemical Analysis

Analyte
Concentration (mg/L)

Na
29,500

Ca
8,210

Mg
1,080

Cl
61,800

SO₄
1,300

HCO₃
662

Total Dissolved Solids
102,552

The corrosion rate (CR) in mils per year was calculated for each corrosion inhibitor formulation using equation (1):

C
⁢
R

=

Δ
⁢
W
×
22

,
TagBox[",", "NumberComma", Rule[SyntaxForm, "0"]]

300

D
×
A
×
T

×
1
⁢
00
⁢
%

,

(
1
)

where ΔW is the weight loss of coupon in milligrams, D is the density of the carbon steel coupons (7.89 g/cm³), A is the area of the exposed coupon (7.86 square inches) and T is the exposure time (24 hours). The corrosion rate of each corrosion inhibitor formulation is provided in Table 4.

The corrosion inhibition efficiency (IE %) of each corrosion inhibitor formulation was calculated using equation (2):

IE
⁢

%
⁢

=

(

C
⁢

R

b
⁢
l
⁢
a
⁢
n
⁢
k

-

C
⁢

R

i
⁢
n
⁢
h
⁢
i
⁢
b

)

C
⁢

R

b
⁢
l
⁢
a
⁢
n
⁢
k

×
1
⁢
0
⁢
0
⁢
%

,

(
2
)

where CR_blankis the corrosion rate without inhibitor and CR_inhibis the corrosion rate with the inhibitor. The corrosion inhibition efficiency of each corrosion inhibitor formulation is provided in Table 4.

TABLE 4

Corrosion Inhibition Efficiency of

Corrosion Inhibitor Formulations

Corrosion
Concentration
Corrosion Rate
Corrosion Inhibition

Inhibitor
(ppm)
(mils per year)
Efficiency (%)

CIF-1
10
4.8
70.5

CCIF-1
20
8.1
49.5

CCIF-2
100
9.9
38.0

CCIF-3
10
9.6
40.3

The corrosion inhibition results shown in Table 4 indicate that CIF-1, which includes Active Component 1, exhibited significantly superior corrosion inhibition efficiency to all the comparative corrosion inhibitor formulations. In particular, CIF-1 exhibited superior performance to CCIF-3, which is a conventional corrosion inhibitor formulation used to inhibit corrosion in gas oil separation plants in a wet sour environment in the oil and gas industry. Further, CIF-1 exhibited superior corrosion inhibition efficiency to CCIF-1, even at half the concentration. CIF-1 and CCIF-1 are identical other than the presence of the hydroxyl group on the alkyl chain of the active component. Thus, a comparison of CIF-1 and CCIF-1 reveals that the presence of the hydroxyl group on the active component plays a crucial role in achieving the improved corrosion inhibition efficiency of CIF-1.

The corrosion inhibition results shown in Table 4 also reveal that imidazoline is not responsible for the majority of the corrosion inhibition efficiency exhibited in corrosion inhibitor formulations according to embodiments described herein. In particular, comparing CIF-1, which contains 15 weight % Active Component 1 and 5 weight % imidazoline, with CCIF-2, which contains 20 weight % imidazoline, reveals that CIF-1 is superior to CCIF-2 in corrosion inhibition efficiency even at one tenth the concentration. Comparing the corrosion inhibition efficiency of CCIF-1 with CCIF-2 also reveals that an active component comprising a pyridinium on an alkyl chain absent a hydroxyl group provides superior corrosion inhibition performance to imidazoline, even at one fifth the concentration. Thus, it is believed that the presence of both the pyridinium and the hydroxyl group on Active Component 1 is responsible for the improved corrosion inhibition exhibited by CIF-1 compared with CCIF-1, CCIF-2, and CCIF-3.

It should be understood that any ranges provided herein include the endpoints unless stated otherwise.

It should be understood that any two quantitative values assigned to a property may constitute a range of that property, and all combinations of ranges formed from all stated quantitative values of a given property are contemplated in this disclosure.

The subject matter of the present disclosure has been described in detail and by reference to specific embodiments. It should be understood that any detailed description of a component or feature of an embodiment does not necessarily imply that the component or feature is essential to the particular embodiment or to any other embodiment. Further, it should be apparent to those skilled in the art that various modifications and variations can be made to the described embodiments without departing from the spirit and scope of the claimed subject matter.